Evidence map›Paper›PMID 39459407›Full record

Observational studyMedicina (Kaunas, Lithuania)2024

Amikacin Liposomal Inhalation Suspension for Non-Tuberculous

Angeliki A Loukeri, Evgenia Papathanassiou, Aikaterini Kavvada, Christos F Kampolis, Ioannis Pantazopoulos, Charalambos Moschos, Apostolos Papavasileiou

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Medicina (Kaunas, Lithuania), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Angeliki A LoukeriDepartment of Mycobacterial Diseases, "Sotiria" Hospital, 11527 Athens, Greece.
Evgenia PapathanassiouDepartment of Mycobacterial Diseases, "Sotiria" Hospital, 11527 Athens, Greece.
Aikaterini KavvadaDepartment of Mycobacterial Diseases, "Sotiria" Hospital, 11527 Athens, Greece.
Christos F KampolisDepartment of Emergency Medicine, "Hippokration" General Hospital of Athens, 11527 Athens, Greece.
Ioannis PantazopoulosDepartment of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Mezourlo, 41110 Larissa, Greece.ORCID 0000-0002-8846-519X
Charalambos MoschosDepartment of Mycobacterial Diseases, "Sotiria" Hospital, 11527 Athens, Greece.
Apostolos PapavasileiouDepartment of Mycobacterial Diseases, "Sotiria" Hospital, 11527 Athens, Greece.ORCID 0000-0002-5060-2910

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AmikacinAnti-Bacterial AgentsLiposomesAdministration, InhalationAgedAged, 80 and overFemaleGreeceHumansLung DiseasesMaleMiddle AgedMycobacterium Infections, NontuberculousRetrospective StudiesTreatment OutcomeAmikacinAnti-Bacterial AgentsLiposomesaminoglycosideinhalationliposomemycobacterial infectionsMycobacterium abscessusMycobacterium avium complex

Identifiers

PMID39459407
PMCPMC11509699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.